Skip to main content

Day: April 26, 2024

Interim Report – January-March 2024

STOCKHOLM – 26 April 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report – January-March 2024. The full report is available on the Company’s website. “2024 has begun strongly with development within the respective portfolio companies proceeding according to plan. The adverse market climate we have previously experienced notwithstanding, our portfolio companies have continued tirelessly to advance the development of tomorrow’s treatments in order that patients can reap the benefits as quickly as possible. We look forward to an increasing tailwind and further progress during the year”, says Viktor Drvota, CEO, Karolinska Development. Significant events during the first quarterThe portfolio company OssDsign reported positive data from the clinical study TOP FUSION. Top-line results show...

Continue reading

Riber: 2024 first quarter revenues: +20%

2024 first quarter revenues: +20% Order book at the end of March 2024: +4% Bezons, April 26, 2024 – 8:00am (CET) – RIBER, the global leader for molecular beam epitaxy (MBE) equipment serving the semiconductor industry, is reporting its revenues for the first quarter of 2024. Change in revenuesAt March 31 (€m) 2024 2023 ChangeSystems 2.0 1.9 +6%Services and accessories 2.5 1.8 +35%Total quarterly revenues 4.5 3.7 +20%2024 first-quarter revenues amounted to €4,5m, up +20%. Revenues for MBE systems increased by 6% to €2.0m and included billing for one machine. Revenues for services and accessories rose by 35% to €2.5m. At end-March 2024, the geographical breakdown of the Company’s revenues was as follows: 71% in Europe, 21% in Asia and 8% in North America. Order book developmentsAt March 31 (€m) 2024 2023 ChangeSystems 27.9 26.7 +5%Services...

Continue reading

Progress on ABN AMRO share buyback programme 19 April – 25 April 2024

Progress on ABN AMRO share buyback programme 19 April – 25 April 2024 ABN AMRO reports the transaction details related to its EUR 500 million share buyback programme announced on 14 February 2024. During the week of 19 April 2024 up to and including 25 April 2024 a total of 3,000,000 shares and depositary receipts were repurchased at an average price of €15.72 for a total amount of €47,170,980. For detailed information on the daily repurchased shares and depositary receipts, individual share purchase transactions and weekly reports, see the ABN AMRO website at https://www.abnamro.com/en/investor-relations/information/share-buyback-programme. To date the total consideration for shares and depositary receipts repurchased amounts to €452,072,460 representing 90.41% of the overall share buyback programme.ABN AMRO Press Office ABN AMRO...

Continue reading

Falcon Oil & Gas – Shenandoah South-1H well IP90 Day Flow Rates of 2.9 MMcf/d (normalised to 5.8 MMcf/d)

Falcon Oil & Gas Ltd.(“Falcon” or “Company”) Shenandoah South-1H well IP90 Day Flow Rates of 2.9 MMcf/d (normalised to 5.8 MMcf/d) 26 April 2024 – Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) is pleased to announce that the Shenandoah South 1H (SS-1H) well in EP117 achieved above commercial IP90 flow rate of 2.9 MMcf/d (normalised to 5.8 MMcf/d over 1,000 metres). Highlights are as follows:The SS-1H well in EP117 achieved an average 90-day initial production (IP90) flow rate of 2.9 million cubic feet per day (MMcf/d) over the 1,644-foot (501 metres), 10 stage stimulated length within the Amungee Member B-Shale, normalised to 5.8 MMcf/d over 3,281-feet (1,000 metres). On completion of the IP90 flow test, the well was delivering 2.7 MMcf/d, normalized to 5.4 MMcf/d over 3,281-feet (1,000 metres) at a pressure of 518 psi prior to...

Continue reading

Lassila & Tikanoja plc: Interim Report 1 January–31 March 2024

Lassila & Tikanoja plc Stock exchange release 26 April 2024 at 8:00 a.m. Lassila & Tikanoja plc: Interim Report 1 January–31 March 2024 STABLE RESULT IN THE FINNISH DIVISIONS – FACILITY SERVICES SWEDEN DID NOT MEET EXPECTATIONS Unless otherwise mentioned, the figures in brackets refer to the corresponding period in the previous year.Net sales for the first quarter were EUR 185.0 million (192.7). Net sales decreased by 4.0%. The decline in net sales was due to the weak economic environment. Adjusted operating profit was EUR 0.0 million (1.4) and operating profit was EUR -1.7 million (1.4). Earnings per share were EUR -0.02 (0.03). Net cash flow from operating activities after investments was EUR -9.4 million (19.2) and net cash flow from operating activities after investments per share was EUR -0.25 (0.50). Net cash flow was...

Continue reading

Apranga Group interim report for 3 months 2024

The retail turnover (including VAT) of Apranga Group reached EUR 72.3 million in Q1 2024 and was by 11.0% higher than in 2023. The unaudited consolidated profit before income tax of Apranga Group amounted to EUR 1.3 million in 3 months 2024, while Apranga Group had the profit of EUR 1.4 million in the same period of 2023. EBITDA of Apranga Group reached EUR 6.4 million in 3 months 2024, while it amounted to EUR 6.2 million in corresponding period of 2023. The unaudited interim consolidated financial statements of Apranga Group for 3 months 2024, as well as managers’ confirmation letter are ready for acquaintance in the attachments. The interim information is also available at: http://aprangagroup.lt/en/investors. Rimantas PerveneckasApranga Group General Manager+370 5 2390801      AttachmentFA2024Q1 EN

Continue reading

IMCD reports EBITA of EUR 127 million in the first three months of 2024

IMCD_logoLogo IMCDRotterdam, The Netherlands (26 April 2024) – IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces its first three months 2024 results. HIGHLIGHTSGross profit of EUR 295 million (on a constant currency basis, equal to the first three months of 2023) Operating EBITA decline of 15% to EUR 127 million (-13% on a constant currency basis) Free cash flow of EUR 106 million (first three months of 2023: EUR 147 million) Cash earnings per share decline of 19% to EUR 1.41 (first three months of 2023: EUR 1.74) Successful completion of six acquisitions: Valuetree and CJ Shah in India, Joli Foods in Colombia, RBD in China, Euro Chemo-Pharma/Biofresh in Malaysia and Gova in the BeneluxValerie Diele-Braun, CEO: “In a volatile...

Continue reading

Signify reports first quarter sales of EUR 1.5 billion, operational profitability of 8.3% and a free cash flow of EUR 80 million

Press Release April 26, 2024 Signify reports first quarter sales of EUR 1.5 billion, operational profitability of 8.3% and a free cash flow of EUR 80 million First quarter 20241Signify’s installed base of connected light points increased from 124 million in Q4 23 to 126 million in Q1 24 Achieved reasonable assurance on full Brighter Lives, Better World 2025 program, including scope 3 emissions Sales of EUR 1,468 million; nominal sales decline of -12.5% and CSG of -10.1% LED-based sales represented 87% of total sales (Q1 23: 82%) Adj. EBITA margin of 8.3% (Q1 23: 8.9%) Net income of EUR 44 million (Q1 23: EUR 28 million) Free cash flow of EUR 80 million (Q1 23: EUR 51 million)Eindhoven, the Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, today announced the company’s first quarter 2024 results. “In the...

Continue reading

Corbion: Q1 2024 Interim Management Statement

Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes its results for the quarter ending 31 March 2024. Key highlights first quarter of 2024Organic growth core activities:Sales: volume/mix +1.7%, price -4.5% Adjusted EBITDA: +0.7% Adjusted EBITDA margin 13.8% (+ 50bps versus last year)Sales € 344.3 million; an organic decrease of -3.4% Adjusted EBITDA € 47.2 million; an organic decrease of -1.2% Positive Free Cash Flow € 7.5 million Double digit growth in sales and Adjusted EBITDA in Health & Nutrition TotalEnergies Corbion joint venture: sales € 31.6 million; an organic growth of 24.3% Divestment of non-core US Emulsifier business completed on April 1st Share buyback program of € 20.0 million and special cash dividend of € 0.10 per share Confirmation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.